The stock has received rating from many Reuters analysts. The Analysts at Berenberg lowers the price target from $80 per share to $70 per share.
Advertisement
Bristol-Myers Squibb Company’s (BMY) stock price showed weak performance of -4.19% in last seven days, switched down -21.02% in last thirty days and it fell -0.61% in last one year.
07/06/2016 – Bristol-Myers Squibb Company had its “buy” rating reiterated by analysts at Goldman Sachs. Leerink Swann restated a “buy” rating on shares of Bristol-Myers Squibb in a research report on Wednesday, April 27th.
Bristol-Myers Squibb Company (NYSE:BMY) Soared 0.64 or 0.39 points in order to reach at the price of $60.97. 13 of the brokerages firms have a buy or better rating; the 0 sells versus 2 underperforms. The Average price target is noted at $26.75, this average price is calculated and based on coming up with go through the consensus of analysts and stock’s current price is placed at $24.6. It recently traded in a range of $60.61-$61.3 at a volume of 9372409 shares.
Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with MarketBeat.com’s FREE daily email newsletter. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Charles A. Bancroft sold 30,201 shares of the business’s stock in a transaction dated Friday, May 20th. They now have a Dollars 69 price target on the stock. A Director in the company, Andreotti Lamberto, on Tuesday June 28, 2016 collected $1,673,650 from the sale of 23,200 shares at a per-share price of $74.45. The disclosure for this sale can be found here. 5,802,083 shares of the company traded hands. The simple 20 day moving average stands at -16.43% and the simple 200-day moving average is at -9.98%. Bristol-Myers Squibb Company (NYSE:BMY) 52-week high is $77.1200 and the 52-week low is $51.8200. It has market cap of $101.30B.
Bristol-Myers Squibb (NYSE:BMY) last issued its quarterly earnings data on Thursday, July 28th. For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.56 per share according to consensus of 19 analysts.
The consensus mean EPS for the current quarter is at 0.64 derived from a total of 19 estimates. During the same quarter previous year, the firm earned $0.53 EPS. Revenue for the quarter was $4.29B while analysts had expected revenues to come in at $4.15B. On May 9, 2016, Credit Suisse said it Maintains its rating on Bristol-Myers Squibb Co. Shareholders of record on Friday, October 7th will be issued a dividend of $0.38 per share. This represents a $1.52 dividend on an annualized basis and a dividend yield of 2.51%. The dividend payable date has been fixed on Nov 1, 2016.
A number of large investors have bought and sold shares of BMY. The company’s strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, compelling growth in net income and good cash flow from operations.
Ford Motor Company (NYSE:F)’s values for SMA20, SMA50 and SMA200 are -4.45%, -4.32% and -4.14%, respectively.
Advertisement
05/23/2016 – Hilliard Lyons began new coverage on Bristol-Myers Squibb Company giving the company a “neutral” rating. Finally, BTC Capital Management Inc. acquired a new stake in Bristol-Myers Squibb during the first quarter valued at approximately $215,000.
